NERV Minerva Neurosciences, Inc.
Price Chart
Executive Summary
Minerva Neurosciences, Inc. (NERV) filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, disclosing key governance matters including director elections, executive compensation, and auditor ratification. This filing follows a recent settlement agreement with former President Geoff Race, which may influence shareholder sentiment and voting behavior on the proposed board nominees and compensation matters.
Actionable Insight
Monitor the shareholder vote on June 3, 2026, particularly on director elections and executive compensation, as the recent settlement with the former president may influence voting outcomes.
Key Facts
- The filing is a definitive proxy statement (DEFA14A) for Minerva Neurosciences' 2026 Annual Meeting.
- Proposals include electing two Class III directors (David Kupfer and Jan van Heek), approving amendments to the company's certificate of incorporation, approving executive compensation, and ratifying the auditor.
- The filing is preceded by a settlement agreement (8-K) with former President Geoff Race, which included a termination payment and waiver of claims.
- The meeting date is June 3, 2026, with a vote deadline of June 2, 2026.
Financial Impact
The settlement with Geoff Race involved a termination payment, but the specific amount is not disclosed in the provided documents.
Risk Factors
- The settlement with the former president could lead to shareholder scrutiny of board decisions and executive compensation.
- The proposed amendments to the certificate of incorporation may face opposition if not clearly communicated.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-171805 |
| Document: 0001193125-26-171805-index-headers.html | 0001193125-26-171805 |
| Document: 0001193125-26-171805-index.html | 0001193125-26-171805 |
| Document: 0001193125-26-171805.txt | 0001193125-26-171805 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 27, 2026
13d ago
|
8-K
| $5.00 $4.78 | ▲ +4.40% | ▲ +4.72% | $4.74 (+5.20%) |
|
May 5, 2026
5w ago
|
8-K
| $6.25 $5.63 | ▼ −9.92% | ▼ −11.90% | $4.74 (−24.16%) |
|
Apr 23, 2026
6w ago
|
DEFA14A
| $6.83 $6.39 | ▼ −6.44% | ▼ −7.92% | $4.74 (−30.60%) |
|
Mar 25, 2026
10w ago
|
Press Release
| $6.14 $5.28 | ▼ −14.01% | ▼ −15.64% | $4.74 (−22.80%) |
|
Mar 20, 2026
11w ago
|
EFFECT
| $7.54 $6.18 | ▼ −18.04% | ▼ −15.89% | $4.74 (−37.14%) |
|
Mar 11, 2026
12w ago
|
S-3
| $7.30 $7.78 | ▼ −6.58% | ▼ −8.76% | $4.74 (+35.07%) |
|
Mar 11, 2026
12w ago
|
Press Release
| $7.30 $7.78 | ▲ +6.58% | ▲ +8.76% | $4.74 (−35.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access